LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -98.61%-5.59M | -254.57%-7.25M | -152.93%-6.44M | 7.80%-10.8M | -87.77%-3.39M | -19.29%-2.81M | 24.73%-2.05M | 47.26%-2.55M | 22.61%-11.71M | 37.67%-1.81M |
Net income from continuing operations | -48.04%-5.65M | -1,269.62%-10.05M | -157.83%-6.71M | 10.72%-12.47M | -13.64%-5.31M | -22.65%-3.82M | 77.78%-734K | 9.43%-2.6M | 8.62%-13.97M | -2.14%-4.68M |
Operating gains losses | -441.38%-297K | 104.33%133K | -16.67%70K | 47.87%-2.96M | 99.06%-54K | --87K | ---3.07M | --84K | ---5.67M | ---5.74M |
Depreciation and amortization | 400.00%5K | --6K | 300.00%4K | -70.00%6K | 300.00%4K | -50.00%1K | --0 | -91.67%1K | -58.33%20K | -91.67%1K |
Other non cash items | --3K | --0 | --1K | -99.99%1K | -100.05%-4K | ---- | ---- | ---- | 34,141.67%8.22M | 136,733.33%8.21M |
Change In working capital | -71.18%213K | 45.60%2.53M | 100.00%92K | 476.46%4.4M | 919.02%1.88M | 38.39%739K | 492.83%1.74M | 102.11%46K | -100.00%-1.17M | -87.51%184K |
-Change in prepaid assets | 101.27%316K | 4.35%192K | -39.24%-699K | 9.38%70K | -66.57%231K | -57.57%157K | -64.13%184K | 66.75%-502K | -83.84%64K | 12.36%691K |
-Change in payables and accrued expense | -117.70%-103K | 50.48%2.34M | 44.34%791K | 451.22%4.33M | 424.26%1.64M | 254.88%582K | 805.91%1.55M | 181.91%548K | -25.71%-1.23M | -159.09%-507K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -98.61%-5.59M | -254.57%-7.25M | -152.93%-6.44M | 7.80%-10.8M | -87.77%-3.39M | -19.29%-2.81M | 24.73%-2.05M | 47.26%-2.55M | 22.61%-11.71M | 37.67%-1.81M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -3K | -25.00%-5K | -725.00%-50K | -9K | -37K | 0 | -4K | 101.37%8K | 0 |
Net PPE purchase and sale | --0 | ---3K | -25.00%-5K | -725.00%-50K | ---9K | ---37K | --0 | ---4K | 366.67%8K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | ---3K | -25.00%-5K | -725.00%-50K | ---9K | ---37K | --0 | ---4K | 101.37%8K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -676K | -100.28%-80K | 0 | 0 | 30.21%28.68M | 123.61%28.82M | ||||
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --32.25M | ---- |
Net other financing activities | ---676K | ---- | ---- | 97.76%-80K | --0 | --0 | ---- | ---- | -70.85%-3.57M | -196.89%-3.44M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---676K | 24,100.00%19.2M | --0 | -100.28%-80K | --0 | --0 | ---80K | --0 | 30.21%28.68M | 123.61%28.82M |
Net cash flow | ||||||||||
Beginning cash position | -2.63%27.93M | -48.11%15.99M | -32.76%22.44M | 103.60%33.36M | 306.50%25.84M | 224.19%28.69M | 166.62%30.81M | 103.60%33.36M | 62.42%16.39M | -8.99%6.36M |
Current changes in cash | -119.75%-6.27M | 662.16%11.95M | -152.72%-6.45M | -164.38%-10.93M | -112.60%-3.4M | -14.36%-2.85M | 21.56%-2.13M | 47.17%-2.55M | 169.22%16.98M | 187.20%27.01M |
End cash Position | -16.13%21.67M | -2.63%27.93M | -48.11%15.99M | -32.76%22.44M | -32.76%22.44M | 306.50%25.84M | 224.19%28.69M | 166.62%30.81M | 103.60%33.36M | 103.60%33.36M |
Free cash flow | -96.04%-5.59M | -254.72%-7.25M | -152.72%-6.45M | 7.37%-10.85M | -88.27%-3.4M | -20.86%-2.85M | 24.73%-2.05M | 47.17%-2.55M | 22.63%-11.71M | 37.67%-1.81M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |